Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Advanced Malignant Solid Neoplasm × dinaciclib × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Multiple Myeloma 2 Melanoma 2 Triple Negative Breast Neoplasms 1 Pancreatic Neoplasms 1 Leukemia, Prolymphocytic 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Breast Neoplasms, Male 1 Breast Neoplasms 1 Advanced Malignant Solid Neoplasm 1

Interventions

veliparib 2 adavosertib 2 trametinib 1 dinaciclib 1 Temozolomide 1 Everolimus 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01434316 2026-04-13

Veliparib and Dinaciclib in Treating Patients With Advanced Solid Tumors

National Cancer Institute (NCI)

Phase 1 Active not recruiting

Other solid neoplasm

Advanced Malignant Solid Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡